David Waespe, MD
Adult Reconstructive Orthopaedic Surgery · Georgetown, KYNPI 1790915239
Payments from drug & device makers
Across 111 payments — averaging $75.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$6K
- Johnson & Johnson$2K
- Smith+Nephew$185
- Intuitive Surgical$135
- Stryker$125
- Zimmer Biomet$99
- plus $475 from 18 others
What the payments were for
- Consulting fees$5,58067%
- Food & beverage$2,74533%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 5 | $5,676 |
| Johnson & Johnson(2 entities) | 71 | $1,631 |
| Smith+Nephew | 3 | $185 |
| Intuitive Surgical | 1 | $135 |
| Stryker(2 entities) | 4 | $125 |
| Zimmer Biomet | 3 | $99 |
| Ferring Pharmaceuticals Inc. | 6 | $91 |
| Novo Nordisk | 1 | $82 |
| Bioventus LLC | 2 | $34 |
| Acumed LLC | 1 | $33 |
| Argentum Medical | 1 | $27 |
| DJO, LLC | 1 | $25 |
| KCI USA, Inc. | 1 | $20 |
| Medartis Inc. | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Si-bone, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $15 |
| Glaukos Corporation | 1 | $15 |
| Covidien LP | 1 | $12 |
| Iroko Pharmaceuticals, LLC | 1 | $11 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult reconstructive orthopaedic surgery providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $9,071 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 326 | $3,781 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 244 | $1,784 |
| Celecoxib | 25 | $894 |
| Diclofenac Sodium | 44 | $608 |
| Tramadol Hcl | 59 | $284 |
| Methylprednisolone | 44 | $265 |
| Gabapentin | 30 | $248 |
| Methocarbamol | 14 | $208 |
| Cyclobenzaprine Hcl | 39 | $146 |
| Tizanidine Hcl | 11 | $127 |
| Meloxicam | 24 | $68 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $36 |
| Amoxicillin | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Georgetown
- Stephen DuncanLexington$1.2M
- James BakerLouisville$200K
- Saul FredricksonEdgewood$34K
- Samrath BhimaniLouisville$10K
- Prodromos VervereliTaylorsville$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.